The FDA approved Cleveland Diagnostics' blood-based test to help diagnose high-grade prostate tumors and aid in biopsy decisions, the company announced.

After surgery for prostate cancer, Todd Elworthy’s PSA came back elevated. Radiation was advised as the next step and Elworthy looked into a Fred Hutch clinical trial and proton therapy. Though he ...

The blood-based test is intended to aid in the decision for prostate biopsy for men older than 50 with elevated PSA levels.

The charity is funding a research trial called Transform which is looking to find the safest, most accurate and ...

Profound Medical (PROF) announced the upcoming launch of its TULSA-AI Volume Reduction module for optimizing the treatment of patients with benign ...

Mechanical ventilation highlights the fundamental paradox of critical care: it can be both life-saving and life-threatening.

For clinicians, bladder stones (vesical calculi) are less a disease and more a symptom of a deeper problem, usually stasis or ...